Claris Lifesciences is currently trading at Rs. 360.00, up by 12.65 points or 3.64% from its previous closing of Rs. 347.35 on the BSE.
The scrip opened at Rs. 367.00 and has touched a high and low of Rs. 374.40 and Rs. 356.70 respectively. So far 182581 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 430.10 on 16-Dec-2016 and a 52 week low of Rs. 280.00 on 02-Dec-2016.
Last one week high and low of the scrip stood at Rs. 374.40 and Rs. 340.05 respectively. The current market cap of the company is Rs. 1975.90 crore.
The promoters holding in the company stood at 50.13%, while institutions and non-institutions held 27.56% and 22.31% respectively.
Claris Lifesciences has received a letter from the promoter Athanas Enterprise to consider delisting of shares of the pharma company from the stock exchange. The promoter/promoter group currently holds 50.13% of the share capital of the company.
The promoter along with the promoter/promoter group of the company has expressed its intention to make a voluntary delisting offer, either by itself or along with one or more subsidiaries to acquire 2,72,11,801 equity shares of Rs 10 each representing 49.87% of the paid up share capital of the company held by the public shareholders and accordingly delist the equity shares of the company from the exchange.
Further, the promoter has requested the board of directors of the company to consider and approve the delisting proposal in accordance with the regulations.
Claris Lifesciences is engaged in manufacturing of drugs and pharmaceutical products. The Company manufactures and markets products across multiple delivery systems, markets and therapeutic segments, including anesthesia and analgesics, blood products, anti-invective's, critical care, and nephrology.
Company Name | CMP |
---|---|
Redington | 190.20 |
Adani Enterprises | 2257.65 |
Amrapali Industries | 17.95 |
Rashi Peripheral | 371.95 |
Compuage Infocom | 2.54 |
View more.. |